Abstract Solicitation
The Genetics and Epigenetics Cross-Cutting Research Team of the National Institute on Drug Abuse invites you to submit an abstract for the May 23-24, 2024, NIDA Genetics and Epigenetics Cross-Cutting Research Team Meeting. We will hold this in-person meeting at Natcher Auditorium on the NIH Campus in Bethesda, MD.
Abstract submission is due no later than Thursday, February 15, 2024. No late abstracts will be accepted.
Please submit your Abstract in the following format to NGCAbstracts@sdsolutionsllc.com:
| Submitter Name: | Submitted Email: |
| PI Name (if different): | PI Email (if different): |
Clever title for your Abstract
First Name Last Name1, First Name Last Name1,2, First Name Last Name3, and First Name Last Name1,4
1Department, University; 2Department, University; 3Department, University; 4Department, University
The Abstract should discuss the background, rationale/significance, hypothesis, results, and discussion. The font size should be Arial 11 pt. The body of the Abstract should be 250 words maximum and fully justified. Please submit the Abstract as a Word document. Abstracts are due by Midnight PST on February 5, 2024. Abstracts not conforming to this format or sent to another email will not be accepted for review and may be returned to the sender. Abstracts sent to another email will not be returned.
See examples at: (NIDA Genetics Consortium Meeting Abstracts).
The goals of the meeting are to:
- Showcase the exciting research on the genetics and epigenetics of substance use disorders
- Encourage collaboration amongst investigators with different expertise in genetics and epigenetics
- Foster collaboration and new research among investigators working on the genetics and epigenetics of addiction and HIV/AIDS, mental health, and other comorbidities
- Identify new research opportunities in the genetics and epigenetics of addiction
- Provide attendees with an opportunity to meet with NIDA program directors to discuss their ideas for grant applications and funding opportunities
The NIDA Genetics and Epigenetics Cross-Cutting Research Team will select up to 20 abstracts for short talks and up to 140 abstracts for poster presentations. We may invite some investigators to serve as panel discussants. Abstracts should focus on the genetics and epigenetics of substance abuse in humans or in model systems. We encourage submissions across all career stages (e.g. graduate students, postdoctoral scientists, junior and senior faculty). Abstracts are due by Midnight PST on February 5, 2024. Decisions on acceptance of poster presentations and short talks will be made on a rolling basis. Please email your Abstract to: NGCAbstracts@sdsolutionsllc.com.
There is no registration fee to attend this meeting, however, attendees are responsible for their own travel, meals, and lodging.
